• 1
    Yang RY, Rabinovich GA, Liu FT. Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 2008; 10: e17.
  • 2
    Seelenmeyer C, Wegehingel S, Tews I, K¨nzler M, Aebi M, Nickel W. Cell surface counter receptors are essential components of the unconventional export machinery of galectin-1. J Cell Biol 2005; 171: 373-381.
  • 3
    Martinez VG, Pellizzari EH, Díaz ES, Cigorraga SB, Lustig L, Denduchis B, et al. Galectin-1, a cell adhesion modulator, induces apoptosis of rat Leydig cells in vitro. Glycobiology 2004; 14: 127-137.
  • 4
    Elola MT, Chiesa ME, Alberti AF, Mordoh J, Fink NE. Galectin-1 receptors in different cell types. J Biomed Sci 2005; 12: 13-29.
  • 5
    Elola MT, Wolfenstein-Todel C, Troncoso MF, Vasta GR, Rabinovich GA. Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci 2007; 64: 1679-1700.
  • 6
    Rabinovich GA, Ilarregui JM. Conveying glycan information into T-cell homeostatic programs: a challenging role for galectin-1 in inflammatory and tumor microenvironments. Immunol Rev 2009; 230: 144-159.
  • 7
    Hsu DK, Dowling CA, Jeng KC, Chen JT, Yang RY, Liu FT. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 1999; 81: 519-526.
  • 8
    Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, et al. Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res 1999; 59: 4990-4996.
  • 9
    Kondoh N, Hada A, Ryo A, Shuda M, Arai M, Matsubara O, et al. Activation of galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements. Int J Oncol 2003; 23: 1575-1583.
  • 10
    Chung EJ, Sung YK, Farooq M, Kim Y, Im S, Tak WY, et al. Gene expression profile analysis in human hepatocellular carcinoma by cDNA microarray. Mol Cell 2002; 14: 382-387.
  • 11
    Spano D, Russo R, Di Maso V, Rosso N, Terracciano LM, Roncalli M, et al. Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness. Mol Med 2010; 16: 102-115.
  • 12
    Haussinger D, Kubitz R, Reinhehr R, Bode JG, Schiess F. Molecular aspects of medicine: from experimental to clinical hepatology. Mol Aspects Med 2004; 25: 221-360.
  • 13
    Hikita C, Vijayakumar S, Takito J, Erdjument-Bromage H, Tempst P, Al-Awqati Q. Induction of terminal differentiation in epithelial cells requires polymerization of hensin by galectin 3. J Cell Biol 2000; 151: 1235-1246.
  • 14
    Delacour D, Greb C, Koch A, Salomonsson E, Leffler H, Le Bivic A, et al. Apical sorting by galectin-3-dependent glycoprotein clustering. Traffic 2007; 8: 379-388.
  • 15
    Delacour D, Koch A, Ackermann W, Eude-Le Parco I, Elsässer HP, Poirier F, et al. Loss of galectin-3 impairs membrane polarisation of mouse enterocytes in vivo. J Cell Sci 2008; 121: 458-465.
  • 16
    Delacour D, Gouyer V, Zanetta JP, Drobecq H, Leteurtre E, Grard G, et al. Galectin-4 and sulfatides in apical membrane trafficking in enterocyte-like cells. J Cell Biol 2005; 169: 491-501.
  • 17
    Mishra R, Grzybek M, Niki T, Hirashima M, Simons K. Galectin-9 trafficking regulates apical-basal polarity in Madin-Darby canine kidney epithelial cells. Proc Natl Acad Sci U S A 2010; 107: 17633-17638.
  • 18
    Zegers MM, Hoekstra D. Sphingolipid transport to the apical plasma membrane domain in human hepatoma cells is controlled by PKC and PKA activity: a correlation with cell polarity in HepG2 cells. J Cell Biol 1997; 138: 307-321.
  • 19
    Larocca MC, Soria LR, Espelt MV, Marinelli RA. Knockdown of hepatocyte aquaporin-8 by RNA interference induces defective bile canalicular water transport. Am J Physiol Gastrointest Liver Physiol 2009; 296: G93-G100.
  • 20
    Roma MG, Milkiewicz P, Elias E, Coleman R. Control by signaling modulators of the sorting of canalicular transporters in rat hepatocyte couplets: role of the cytoskeleton. HEPATOLOGY 2000; 32: 1342-1356.
  • 21
    Wojtal KA, Diskar M, Herberg FW, Hoekstra D, van Ijzendoorn SC. Regulatory subunit I-controlled protein kinase A activity is required for apical bile canalicular lumen development in hepatocytes. J Biol Chem 2009; 284: 20773-20780.
  • 22
    Fajka-Boja R, Blaskó A, Kovács-Sólyom F, Szebeni GJ, Tóth GK, Monostori E. Co-localization of galectin-1 with GM1 ganglioside in the course of its clathrin- and raft-dependent endocytosis. Cell Mol Life Sci 2008; 65: 2586-2593.
  • 23
    Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta 2002; 1572: 263-273.
  • 24
    van den Brˆle FA, Buicu C, Baldet M, Sobel ME, Cooper DN, Marschal P et al. Galectin-1 modulates human melanoma cell adhesion to laminin. Biochem Biophys Res Commun 1995; 209: 760-767.
  • 25
    van den Brˆle F, Califice S, Garnier F, Fernandez PL, Berchuck A, Castronovo V. Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin. Lab Invest 2003; 83: 377-386.
  • 26
    Moiseeva EP, Williams B, Goodall AH, Samani NJ. Galectin-1 interacts with beta-1 subunit of integrin. Biochem Biophys Res Commun 2003; 310: 1010-1016.
  • 27
    Fischer C, Sanchez-Ruderisch H, Welzel M, Wiedenmann B, Sakai T, André S, et al. Galectin-1 interacts with the alpha5beta1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. J Biol Chem 2005; 280: 37266-37277.
  • 28
    Fortin S, Le Mercier M, Camby I, Spiegl-Kreinecker S, Berger W, Lefranc F, et al. Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cells. Brain Pathol 2008; 20: 29-39.
  • 29
    Volpes R, van den Oord JJ, Desmet VJ. Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol 1993; 142: 1483-1492.
  • 30
    Masumoto A, Arao S, Otsuki M. Role of integrins in adhesion and invasion of hepatocellular carcinoma cells. HEPATOLOGY 1999; 29: 68-74.
  • 31
    Zhao Y, Sato Y, Isaji T, Fukuda T, Matsumoto A, Miyoshi E, et al. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J 2008; 275: 1939-1948.
  • 32
    Nejjari M, Hafdi Z, Gouysse G, Fiorentino M, Béatrix O, Dumortier J, et al. Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma: an in vivo and in vitro study. HEPATOLOGY 2002; 36: 418-426.
  • 33
    Mizuno H, Ogura M, Saito Y, Sekine W, Sano R, Gotou T, et al. Changes in adhesive and migratory characteristics of hepatocellular carcinoma (HCC) cells induced by expression of alpha3beta1 integrin. Biochim Biophys Acta 2008; 1780: 564-570.
  • 34
    Stupack DG. Integrins as a distinct subtype of dependence receptors. Cell Death Differ 2005; 12: 1021-1030.
  • 35
    Horiguchi N, Arimoto K, Mizutani A, Endo-Ichikawa Y, Nakada H, Taketani S. Galectin-1 induces cell adhesion to the extracellular matrix and apoptosis of non-adherent human colon cancer Colo201 cells. J Biochem 2003; 134: 869-874.
  • 36
    Häussinger D, Kurz AK, Wettstein M, Graf D, Vom Dahl S, Schliess F. Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis. Gastroenterology 2003; 124: 1476-1487.
  • 37
    Tanos B, Rodriguez-Boulan E. The epithelial polarity program: machineries involved and their hijacking by cancer. Oncogene 2008; 27: 6939-6957.